Cover Image
市場調查報告書

Altor BioScience Corporation的產品平台分析

Altor BioScience Corporation - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 192460
出版日期 內容資訊 英文 33 Pages
訂單完成後即時交付
價格
Back to Top
Altor BioScience Corporation的產品平台分析 Altor BioScience Corporation - Product Pipeline Review - 2015
出版日期: 2015年03月26日 內容資訊: 英文 33 Pages
簡介

Altor BioScience Corporatio是總公司在美國的生物製藥企業。對癌症、病毒性的感染疾病、發炎、自體免疫疾病治療的免疫療法藥進行藥物研發、開發、商品化。還有也提供抗病毒及抗癌疫苗研究的診斷用試劑。

本報告提供Altor BioScience Corporatio 的治療藥開發平台的現狀及各開發階段比較分析、各藥物標靶、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

目錄

Altor BioScience Corporatio 基本資料

  • Altor BioScience Corporatio 概要
  • 主要資訊
  • 企業資料

Altor BioScience Corporatio :R&D概要

  • 主要的治療範圍

Altor BioScience Corporatio :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Altor BioScience Corporatio :開發中產品概況

  • 在臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Altor BioScience Corporatio :藥物簡介

  • ALT-801
  • ALT-836
  • ALT-803
  • ALT-802
  • ALT-804
  • Antiviral TCR-Ck
  • Antiviral TCR-Ig

Altor BioScience Corporatio :開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Altor BioScience Corporatio :最近的開發平台資訊

Altor BioScience Corporatio :開發休止的計劃

Altor BioScience Corporatio :總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06893CDB

Summary

Global Markets Direct's, 'Altor BioScience Corporation - Product Pipeline Review - 2015', provides an overview of the Altor BioScience Corporation's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Altor BioScience Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Altor BioScience Corporation including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Altor BioScience Corporation's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Altor BioScience Corporation's pipeline products

Reasons to buy

  • Evaluate Altor BioScience Corporation's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Altor BioScience Corporation in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Altor BioScience Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Altor BioScience Corporation and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Altor BioScience Corporation
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Altor BioScience Corporation and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Altor BioScience Corporation Snapshot
    • Altor BioScience Corporation Overview
    • Key Information
    • Key Facts
  • Altor BioScience Corporation - Research and Development Overview
    • Key Therapeutic Areas
  • Altor BioScience Corporation - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Altor BioScience Corporation - Pipeline Products Glance
    • Altor BioScience Corporation - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Altor BioScience Corporation - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Altor BioScience Corporation - Drug Profiles
    • ALT-801
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ALT-836
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ALT-803
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ALT-802
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ALT-804
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Antiviral TCR-Ck
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Antiviral TCR-Ig
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Altor BioScience Corporation - Pipeline Analysis
    • Altor BioScience Corporation - Pipeline Products by Target
    • Altor BioScience Corporation - Pipeline Products by Route of Administration
    • Altor BioScience Corporation - Pipeline Products by Molecule Type
    • Altor BioScience Corporation - Pipeline Products by Mechanism of Action
  • Altor BioScience Corporation - Recent Pipeline Updates
  • Altor BioScience Corporation - Dormant Projects
  • Altor BioScience Corporation - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Altor BioScience Corporation, Key Information
  • Altor BioScience Corporation, Key Facts
  • Altor BioScience Corporation - Pipeline by Indication, 2015
  • Altor BioScience Corporation - Pipeline by Stage of Development, 2015
  • Altor BioScience Corporation - Monotherapy Products in Pipeline, 2015
  • Altor BioScience Corporation - Phase II, 2015
  • Altor BioScience Corporation - Phase I, 2015
  • Altor BioScience Corporation - Preclinical, 2015
  • Altor BioScience Corporation - Pipeline by Target, 2015
  • Altor BioScience Corporation - Pipeline by Route of Administration, 2015
  • Altor BioScience Corporation - Pipeline by Molecule Type, 2015
  • Altor BioScience Corporation - Pipeline Products by Mechanism of Action, 2015
  • Altor BioScience Corporation - Recent Pipeline Updates, 2015
  • Altor BioScience Corporation - Dormant Developmental Projects,2015

List of Figures

  • Altor BioScience Corporation - Pipeline by Top 10 Indication, 2015
  • Altor BioScience Corporation - Pipeline by Stage of Development, 2015
  • Altor BioScience Corporation - Monotherapy Products in Pipeline, 2015
  • Altor BioScience Corporation - Pipeline by Top 10 Target, 2015
  • Altor BioScience Corporation - Pipeline by Top 10 Route of Administration, 2015
  • Altor BioScience Corporation - Pipeline by Top 10 Molecule Type, 2015
  • Altor BioScience Corporation - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top